Cargando…
M2b macrophages stimulate lymphangiogenesis to reduce myocardial fibrosis after myocardial ischaemia/reperfusion injury
CONTEXT: Therapeutic lymphangiogenesis is a new treatment for cardiovascular diseases. Our previous study showed M2b macrophages can alleviate myocardial ischaemia/reperfusion injury (MI/RI). However, the relation between M2b macrophages and lymphangiogenesis is not clear. OBJECTIVE: To investigate...
Autores principales: | Wang, Cuiping, Yue, Yuan, Huang, Suiqing, Wang, Keke, Yang, Xiao, Chen, Jiantao, Huang, Jiaxing, Wu, Zhongkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865132/ https://www.ncbi.nlm.nih.gov/pubmed/35188856 http://dx.doi.org/10.1080/13880209.2022.2033798 |
Ejemplares similares
-
M2b macrophages protect against myocardial remodeling after ischemia/reperfusion injury by regulating kinase activation of platelet-derived growth factor receptor of cardiac fibroblast
por: Yue, Yuan, et al.
Publicado: (2020) -
Interleukin‐7 aggravates myocardial ischaemia/reperfusion injury by regulating macrophage infiltration and polarization
por: Yan, Mengwen, et al.
Publicado: (2021) -
The cardioprotective potential of valsartan in myocardial ischaemia reperfusion injury
por: Hadi, Najah R., et al.
Publicado: (2015) -
Changes and Relationship of PAF and TNF in Rats with Myocardial Ischaemia and Reperfusion Injury
por: Han, Ya-Ling, et al.
Publicado: (1994) -
Inhibition of adenosine kinase attenuates myocardial ischaemia/reperfusion injury
por: Wang, Wenjun, et al.
Publicado: (2021)